CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLC
Public ClinicalTrials.gov record NCT04681131. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study of BA3011 Alone and in Combination With PD-1 Inhibitor in Adult Patients With Metastatic Non-small Cell Lung Cancer (NSCLC) Who Had Prior Disease Progression on a PD-1/L-1 Inhibitor, EGFR, or ALK Inhibitor.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to assess safety and efficacy of CAB-AXL-ADC in NSCLC
Study identification
- NCT ID
- NCT04681131
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 85 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 17, 2021 (Actual)
- Primary completion
- Jul 9, 2025 (Actual)
- Completion
- Jul 9, 2025 (Actual)
- Last update posted
- Sep 25, 2025
2021 – 2025
United States locations
- U.S. sites
- 32
- U.S. states
- 16
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope - Duarte | Duarte | California | 91010 | — |
| University of California Irvine Medical Center (UCIMC) - Chao Family Comprehensive Cancer Center | Irvine | California | 92868 | — |
| California Research Institute | Los Angeles | California | 90027 | — |
| USC Norris | Los Angeles | California | 90033 | — |
| Cedars-Sinai | Los Angeles | California | 90048 | — |
| University of California, San Diego (UCSD) - Moores Cancer Center | San Diego | California | 92093 | — |
| American Institute of Research | Whittier | California | 90603 | — |
| University of Colorado Anschutz Medical Campus | Aurora | Colorado | 80045 | — |
| Florida Cancer Specialists & Research Institute | Fleming Island | Florida | 32003 | — |
| Florida Cancer Specialists & Research Institute | Fort Myers | Florida | 33916 | — |
| Florida Cancer Specialist | St. Petersburg | Florida | 33705 | — |
| Moffitt Cancer Center | Tampa | Florida | 33612 | — |
| Florida Cancer Specialists | West Palm Beach | Florida | 33401 | — |
| Augusta University - Georgia Cancer Center | Augusta | Georgia | 30912 | — |
| Baptist Health Systems | Lexington | Kentucky | 40503 | — |
| University of Kentucky | Lexington | Kentucky | 40536 | — |
| Norton Cancer Institute, Brownsboro Hospital Campus | Louisville | Kentucky | 40241 | — |
| Hematology/Oncology Clinic | Baton Rouge | Louisiana | 70809 | — |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | — |
| University of Michigan Comprehensive Cancer Center | Detroit | Michigan | 48202 | — |
| Comprehensive Cancer Centers of Nevada | Henderson | Nevada | 89014 | — |
| OptumCare Cancer Care | Las Vegas | Nevada | 89169 | — |
| Roswell Park | Buffalo | New York | 14263 | — |
| NYU Langone Health | New York | New York | 10016 | — |
| FirstHealth Outpatient Cancer Center | Pinehurst | North Carolina | 28374 | — |
| Gabrail Cancer Research Center | Canton | Ohio | 44718 | — |
| The Lindner Research Center at the Christ Hospital | Cincinnati | Ohio | 45219 | — |
| UPMC Cancer Center | Pittsburgh | Pennsylvania | 15232 | — |
| Medical University of South Carolina- Hollings Cancer Center | Charleston | South Carolina | 29407 | — |
| Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | — |
| Mary Crowley Cancer Research | Dallas | Texas | 75230 | — |
| MD Anderson | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04681131, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 25, 2025 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04681131 live on ClinicalTrials.gov.